Opalesque Industry Update - Hedge funds were up 0.92% in May, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index has gained 4.58% year to date. “Developed market equities lead the way to a profitable month for most hedge fund strategies,” says Sol Waksman, founder and president of BarclayHedge. “Japan outperformed as the Nikkei rose 5.6% driven by positive economic news, the S&P 500 gained 1.29% in spite of expectations of rising US interest rates, and the MSCI Europe Index advanced 0.8% in the face of Greek exit fears.” All but two of Barclay's 18 hedge fund indices had gains in May. The Healthcare & Biotechnology Index jumped 5.38%, Pacific Rim Equities gained 2.22%, European Equites were up 1.85%, Merger Arbitrage added 1.41%, and the Equity Long/Short Index gained 1.39%. The Equity Short Bias Index was down 2.14% in May, and has lost 6.35% year to date. Equity Short Bias is the only hedge fund sector with a loss in 2015. After five months, Barclay's Healthcare & Biotechnology leads all hedge fund strategies with a 12.64% gain. Pacific Rim Equities are up 8.02%, Emerging Markets have gained 7.97%, European Equites are up 5.22%, and Merger Arbitrage has added 5.23%. The Barclay Fund of Funds Index gained 0.94% in May, and is up 3.82% for the year. Press release
|
Industry Updates
Barclay Hedge Fund Index Gains 0.92% in May (+4.58 YTD)
Thursday, June 18, 2015
|
|